Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pluda

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancerK S Bauer, W D Figg, J M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancerM A Rudek, W D Figg, V Dyer, et al.
Science (New York, N.Y.)|July 28, 1989
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosineR Yarchoan, H Mitsuya, R V Thomas, et al.
The Journal of Infectious Diseases|October 1, 1993
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infectionB Y Nguyen, L E Shay, K M Wyvill, et al.
Reviews of Infectious Diseases|July 1, 1990
The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profilesR Yarchoan, H Mitsuya, J M Pluda, et al.
The Journal of Infectious Diseases|January 1, 1994
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infectionR Yarchoan, J A Lietzau, B Y Nguyen, et al.
The Journal of Infectious Diseases|June 1, 1995
A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infectionJ M Pluda, T P Cooley, J S Montaner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomasH A Fine, W D Figg, K Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Activity of thalidomide in AIDS-related Kaposi's sarcomaR F Little, K M Wyvill, J M Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, D S Eilender, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancerK S Bauer, W D Figg, J M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancerM A Rudek, W D Figg, V Dyer, et al.
Science (New York, N.Y.)|July 28, 1989
In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosineR Yarchoan, H Mitsuya, R V Thomas, et al.
The Journal of Infectious Diseases|October 1, 1993
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infectionB Y Nguyen, L E Shay, K M Wyvill, et al.
Reviews of Infectious Diseases|July 1, 1990
The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profilesR Yarchoan, H Mitsuya, J M Pluda, et al.
The Journal of Infectious Diseases|January 1, 1994
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infectionR Yarchoan, J A Lietzau, B Y Nguyen, et al.
The Journal of Infectious Diseases|June 1, 1995
A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infectionJ M Pluda, T P Cooley, J S Montaner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomasH A Fine, W D Figg, K Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Activity of thalidomide in AIDS-related Kaposi's sarcomaR F Little, K M Wyvill, J M Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, D S Eilender, et al.
Pageof 6